Form 4 for MDT Medtronic
Accepted 2021-08-04 00:00:00 ET · period of report 2021-08-02 · accession 0001127602-21-023105 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-04 | 2021-08-02 | MDT | Salmon Sean | EVP, Pres Diabetes, Cardiovasc | A - Grant | $0.00 | +5,486 | 33.3K | +20% | $0 |
| D | 2021-08-04 | 2021-08-02 | MDT | Salmon Sean | EVP, Pres Diabetes, Cardiovasc | F - Tax | $131.31 | -2,272 | 27.8K | -8% | -$298.3K |
| DM | 2021-08-04 | 2021-08-02 | MDT | Salmon Sean | EVP, Pres Diabetes, Cardiovasc | A - Grant | $0.00 | +61.7K | 13.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2021-08-02 | A | A | 5,486 | $0.00 | 33,329 | D | — | — | |
| 2 | Common | Ordinary Shares | 2021-08-02 | F | D | 2,272 | $131.31 | 27,843 | D | — | — | (F2) This balance increased by 163 shares due to exempt transactions such as dividend reinvestment. (F1) This amount has been adjusted to correct a mathematical error in exempt transactions such as dividend reinvestment. |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-08-02 | A | A | 46,867 | $0.00 | 46,867 | D | $131.26 · 2022-08-02 to 2031-08-02 | 46,867 Ordinary Shares | (F4) These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. |
| 4 | Derivative | Stock Option (Right to Buy) | 2021-08-02 | A | A | 1,085 | $0.00 | 1,085 | D | $131.26 · 2022-08-02 to 2031-08-02 | 1,085 Ordinary Shares | (F4) These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. |
| 5 | Derivative | Performance Share Units | 2021-08-02 | A | A | 13,714 | $0.00 | 13,714 | D | — · — to — | 13,714 Performance Share Units | (F6) The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 13,714 shares will be issued. The actual number of shares to be issued could range from a low of 2,743 at minimum performance to a high of 27,428 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares. (F5) Each performance share unit represents a contingent right to receive one share of Medtronic common stock. (F7) Vests on August 2, 2024. |